Literature DB >> 2668191

Major integral membrane protein immunogens of Treponema pallidum are proteolipids.

N R Chamberlain1, M E Brandt, A L Erwin, J D Radolf, M V Norgard.   

Abstract

A number of the major pathogen-specific immunogens of Treponema pallidum were characterized recently as amphiphilic, integral membrane proteins by phase partitioning with Triton X-114 (J. D. Radolf, N. R. Chamberlain, A. Clausell, and M. V. Norgard. Infect. Immun. 56:490-498, 1988). In the present study, we demonstrated that the same membrane immunogens (designated as detergent phase proteins [DPPs]) become radiolabeled upon in vitro incubation of T. pallidum with various 3H-labeled fatty acids. Radioimmunoprecipitation with a monoclonal antibody confirmed that the 3H-labeled 47-kilodalton protein corresponded to the well-characterized treponemal antigen with the identical apparent molecular mass. Failure to detect 3H-labeled DPPs following incubation with erythromycin confirmed that protein acylation required de novo protein synthesis by the bacteria. When treponemes were incubated with [3H]myristate, [3H]palmitate, or [3H]oleate, radiolabeled proteins corresponding to the DPPs were detected upon autoradiography. Demonstration that a number of the abundant membrane immunogens of T. pallidum are proteolipids provides information to help clarify their membrane association(s) and may serve to explain their extraordinary immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668191      PMCID: PMC313540          DOI: 10.1128/iai.57.9.2872-2877.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Phenacyl esters of fatty acids via crown ether catalysts for enhanced ultraviolet detection in liquid chromatography.

Authors:  H D Durst; M Milano; E J Kikta; S A Connelly; E Grushka
Journal:  Anal Chem       Date:  1975-09       Impact factor: 6.986

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

5.  Carbon sources utilized by virulent Treponema pallidum.

Authors:  J C Nichols; J B Baseman
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

Review 6.  Proteolipids.

Authors:  M J Schlesinger
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

7.  Properties of conjugated protein immunogens which selectively stimulate delayed-type hypersensitivity.

Authors:  J Coon; R Hunter
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

8.  Amino acid sequence for the peptide extension on the prolipoprotein of the Escherichia coli outer membrane.

Authors:  S Inouye; S Wang; J Sekizawa; S Halegoua; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  Catabolism of glucose and fatty acids by virulent Treponema pallidum.

Authors:  N L Schiller; C D Cox
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.

Authors:  S A Lukehart; S A Baker-Zander; E R Gubish
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

View more
  62 in total

Review 1.  Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms.

Authors:  S F Porcella; T G Schwan
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Spirochaetal lipoproteins and pathogenesis.

Authors:  D A Haake
Journal:  Microbiology       Date:  2000-07       Impact factor: 2.777

3.  Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog.

Authors:  D V Shevchenko; T J Sellati; D L Cox; O V Shevchenko; E J Robinson; J D Radolf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 4.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of Treponema pallidum.

Authors:  David L Cox; Amit Luthra; Star Dunham-Ems; Daniel C Desrosiers; Juan C Salazar; Melissa J Caimano; Justin D Radolf
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

6.  Changes in the surface of Leptospira interrogans serovar grippotyphosa during in vitro cultivation.

Authors:  D A Haake; E M Walker; D R Blanco; C A Bolin; M N Miller; M A Lovett
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Characterization of outer membranes isolated from Treponema pallidum, the syphilis spirochete.

Authors:  J D Radolf; E J Robinson; K W Bourell; D R Akins; S F Porcella; L M Weigel; J D Jones; M V Norgard
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Molecular cloning and characterization of a 35.5-kilodalton lipoprotein of Treponema pallidum.

Authors:  C L Hubbard; F C Gherardini; P J Bassford; L V Stamm
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

9.  The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum.

Authors:  D L Cox; P Chang; A W McDowall; J D Radolf
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Acylation of the 47-kilodalton major membrane immunogen of Treponema pallidum determines its hydrophobicity.

Authors:  N R Chamberlain; L DeOgny; C Slaughter; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.